
The Azrieli Group (TLV: AZRG), Israel’s largest commercial real estate developer, builds, owns and manages malls, retail centers, offices and senior homes. The Azrieli Group was founded in 1983 and in 2010 it went public in the largest IPO in the history of the Tel Aviv Stock Exchange (TASE), raising approx. ILS 2.5 billion (~ $700 million). The Company is included in the prestigious TA-35 and TA-125 indices, as well as in the EPRA (European Public Real Estate Association) index. The Group has properties with a total GLA of approx. 1,330,000 sqm, including 19 malls and retail centers with a GLA of 340,000 sqm, 16 office buildings with a GLA of 637,000 sqm, 4 senior homes with a GLA of 105,000 sqm (around 1,035 units), one hotel in Jerusalem, and 8 properties overseas (mainly in Houston, TX and Austin, TX) with GLA of 246,000 sqm. The Group has a 24% holding in Compass Data Centers, which owns a platform for developing and operating data centers in North America. 91% of the fair value of its investment properties and properties under development relates to domestic properties (in Israel). In addition to the 1,330,000 sqm it already owns, the Azrieli Group has an outstanding pipeline of projects in various development stages, including mega-projects at the best locations in Tel Aviv and throughout Israel, spread over a total of 670,000 sqm. These projects will significantly contribute to the Group's growth in the coming years.
We're tracking Azrieli Group's market expansion
How Azrieli Group's international expansion compares to its competitors
Bars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
Azrieli GroupYou | 0 | 0 | — | 0 | 0 |
Not hiring right now
Sign up to track this company and get alerted the moment something changes.
No active campaigns
Sign up to track this company and get alerted the moment something changes.
Tel Aviv Stock Exchange rose with Teva Pharmaceutical leading gains. Most major indices and stocks increased, while some tech companies declined.
Tel Aviv Stock Exchange rose, with Teva Pharmaceutical leading gains after positive trial results. TA 35 Index hit a new record.
Tel Aviv Stock Exchange rises, with Teva leading gains. Tel Aviv 35 Index hits new record at 2,383.74 points.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Azrieli Group's business, markets, and growth signals.

© 2026 Pubrio. All rights reserved.